185 related articles for article (PubMed ID: 33042924)
1. Profiling
Molina Garay C; Carrillo Sánchez K; Flores Lagunes LL; Jiménez Olivares M; Muñoz Rivas A; Villegas Torres BE; Flores Aguilar H; Núñez Enríquez JC; Jiménez Hernández E; Bekker Méndez VC; Torres Nava JR; Flores Lujano J; Martín Trejo JA; Mata Rocha M; Medina Sansón A; Espinoza Hernández LE; Peñaloza Gonzalez JG; Espinosa Elizondo RM; Flores Villegas LV; Amador Sanchez R; Pérez Saldívar ML; Sepúlveda Robles OA; Rosas Vargas H; Rangel López A; Domínguez López ML; García Latorre EA; Reyes Maldonado E; Galindo Delgado P; Mejía Aranguré JM; Alaez Verson C
Front Pediatr; 2020; 8():586. PubMed ID: 33042924
[No Abstract] [Full Text] [Related]
2. Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.
Guan W; Zhou L; Li Y; Yang E; Liu Y; Lv N; Fu L; Ding Y; Wang N; Fang N; Liu Q; Wang B; Li F; Zhang J; Wang M; Wang L; Jing Y; Li Y; Yu L
Exp Hematol Oncol; 2021 Apr; 10(1):27. PubMed ID: 33836835
[TBL] [Abstract][Full Text] [Related]
3. Mutational Landscape of
Molina Garay C; Carrillo Sánchez K; Flores Lagunes LL; Jiménez Olivares M; Muñoz Rivas A; Villegas Torres BE; Flores Aguilar H; Núñez Enríquez JC; Jiménez Hernández E; Bekker Méndez VC; Torres Nava JR; Flores Lujano J; Martín Trejo JA; Mata Rocha M; Medina Sansón A; Espinoza Hernández LE; Peñaloza Gonzalez JG; Espinosa Elizondo RM; Flores Villegas LV; Amador Sanchez R; Pérez Saldívar ML; Sepúlveda Robles OA; Rosas Vargas H; Jiménez Morales S; Galindo Delgado P; Mejía Aranguré JM; Alaez Verson C
Front Pediatr; 2022; 10():899742. PubMed ID: 35967564
[TBL] [Abstract][Full Text] [Related]
4. The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients.
Qiu QC; Wang C; Bao XB; Yang J; Shen HJ; Ding ZX; Liu H; He J; Yao H; Chen SN; Li Z; Xue SL; Liu SB
Hematology; 2018 Apr; 23(3):131-138. PubMed ID: 28876197
[TBL] [Abstract][Full Text] [Related]
5. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical significance of FLT3 and nucleophosmin mutation in childhood acute myeloid leukemia in Chile.
Cabrera ME; Monardes V; Salgado C; Cares C; Gonzalez C
Hematol Transfus Cell Ther; 2023; 45(1):77-82. PubMed ID: 34690101
[TBL] [Abstract][Full Text] [Related]
7. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
[TBL] [Abstract][Full Text] [Related]
8. FLT3-TKD mutation in childhood acute myeloid leukemia.
Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Wang LY; Chang WH
Leukemia; 2003 May; 17(5):883-6. PubMed ID: 12750701
[TBL] [Abstract][Full Text] [Related]
9. [FLT3 mutations in children with acute myeloid leukemia: a single center study].
Ruan M; Wang YQ; Zhang L; Liu TF; Liu F; Liu XM; Zhang JY; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):863-6. PubMed ID: 22099191
[TBL] [Abstract][Full Text] [Related]
10. [FLT3 Gene Mutations in Acute Myeloid Leukemia].
Ye L; Ji MM; Sun ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):322-7. PubMed ID: 25948179
[TBL] [Abstract][Full Text] [Related]
11. Frequency and Prognostic Relevance of FLT3 Mutations in Saudi Acute Myeloid Leukemia Patients.
Elyamany G; Awad M; Fadalla K; Albalawi M; Al Shahrani M; Al Abdulaaly A
Adv Hematol; 2014; 2014():141360. PubMed ID: 24696688
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features and prognostic factors in adult acute myeloid leukemia patients with FLT3-ITD and CEBPA gene co-mutation].
Pei RR; Zhang RH; Yu JF; Jiang ZX; Sun H; Wan DM; Xie XS; Liu YF; Li T; Sun L
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):297-301. PubMed ID: 32447933
[No Abstract] [Full Text] [Related]
13. French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study.
Garnham A; Bruon F; Berthon C; Lebon D; Parimi M; Polya R; Makhloufi KM; Dramard-Goasdoue MH
Oncol Ther; 2023 Sep; 11(3):375-389. PubMed ID: 37578642
[TBL] [Abstract][Full Text] [Related]
14. FLT3 Gene Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand.
Ei Ei Aung N; Yamsri S; Teawtrakul N; Kamsaen P; Fucharoen S
Med Sci Monit Basic Res; 2022 Nov; 28():e937446. PubMed ID: 36542496
[TBL] [Abstract][Full Text] [Related]
15. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia with FLT3-ITD Mutation].
Liu Y; Ke XY; Wang J; Wang JJ; Jing HM; Dong F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):354-358. PubMed ID: 29665898
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia.
Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Chang WH
Cancer; 2002 Jun; 94(12):3292-8. PubMed ID: 12115363
[TBL] [Abstract][Full Text] [Related]
17. FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia.
Mukda E; Pintaraks K; Sawangpanich R; Wiangnon S; Pakakasama S
Asian Pac J Cancer Prev; 2011; 12(7):1827-31. PubMed ID: 22126574
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014
[TBL] [Abstract][Full Text] [Related]
19. FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia.
Mead AJ; Linch DC; Hills RK; Wheatley K; Burnett AK; Gale RE
Blood; 2007 Aug; 110(4):1262-70. PubMed ID: 17456725
[TBL] [Abstract][Full Text] [Related]
20. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]